Long Trade watch symbols: $CLDX $TSRX $GTXI -$CLDX strongest Trade target for $CLDX = $16.50 Short Trade watch symbols: $VVUS $ATRS – $VVUS strongest $VVUS short cover target = $11.80 Possibly more symbols to come.
Month: June 2013
Cempra’s Platform Potentially Worth Billions In Battling Superbugs And MRSA
Written by StockMatusow.com writers Scott Matusow and Kyle Dennis. Mr.Matusow and Mr. Dennis hold positions in Cempra. During volatile market conditions, many investors decide to sell to protect profit. Investors have seen extraordinary gains so far in 2013 and stocks…
Weekend update for 6.23.2013. Market will not crash — it’s a reset.
Weekend update for 6.23.2013. Market will not crash — it’s a reset and I should have seen this coming better. There will be good trades ahead as there is always opportunity in the market. I will be making some more…
Trade call alert: $PGNX I bought on chart technicals. Price target opinion = $5.30
Trade call alert: $PGNX I bought on chart technicals. Price target opinion = $5.30
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
Glucose is one of the most important chemical structures because it is essential in providing the body with energy. It is integral in the chemical process called aerobic respiration, which generates a usable form of energy. Glycolysis is the beginning…
Edu And Charts – Don’t fight The Sheep And Don’t Be a Sheep
Edu And Charts – Don’t fight The Sheep And Don’t Be a Sheep! Often times I talk about not fighting the herd/sheep when they believe 2+2 = 5. In this video, I give some commentary on how to approach investing…
Chart Update For June 17-21
Chart Update For June 17-21. $MNKD $BIOD $TSRX $GTXI
Wednesday’s Biotech Catalyst Trade Watch List
Today, I list four biotech companies with significant near-term catalysts ahead. Under normal market conditions, these stocks should see decent to very strong appreciation in the short-term. There are various ways to play these catalyst trades. Traders and investors can…
StockMatusow’s New Catalyst run-up trade Due Dilligence.
Some analyst commentary mixed in with my commentary on StockMatusow’s Catalyst trade pick. Phase II trial topline data expected late August, early September. Trial design is a randomized, open-label, parallel design comparing BIOD-123 (ultra-rapid-acting recombinant human insulin) to Humalog in…
Removed Amex Card acceptance from StockMatusow
Removed Amex Card acceptance from StockMatusow. Too many processor issues with it with cards not being accepted by the processor, bad address checks, etc, etc, Sorry for the inconvenience. Scott